Maisi Topology has completed a new round of financing.

36Kr learned that "Mais Topology" recently announced the completion of an angel round of financing of nearly 100 million yuan. This round was led by Zhongke Chuangxing, followed by Shuri Chenxing and Zhengjing Capital. Index Capital served as the exclusive financial advisor. The financing funds will be mainly used for the construction of the company's medical isotope production base in Mianyang and the installation and commissioning of equipment, aiming to achieve the commercial supply of innovative α and β nuclides such as Ac-225, Pb-212, and Cu-67 by the end of 2026.